[HTML][HTML] Immune dysregulation as a driver of idiopathic pulmonary fibrosis

K Shenderov, SL Collins, JD Powell… - The Journal of clinical …, 2021 - Am Soc Clin Investig
Idiopathic pulmonary fibrosis (IPF) affects hundreds of thousands of people worldwide,
reducing their quality of life and leading to death from respiratory failure within years of …

PM2. 5 exposure and asthma development: the key role of oxidative stress

K Liu, S Hua, L Song - Oxidative Medicine and Cellular …, 2022 - Wiley Online Library
Oxidative stress is defined as the imbalance between reactive oxygen species (ROS)
production and the endogenous antioxidant defense system, leading to cellular damage …

[HTML][HTML] Type 2 immunity in tissue repair and fibrosis

RL Gieseck III, MS Wilson, TA Wynn - Nature Reviews Immunology, 2018 - nature.com
Type 2 immunity is characterized by the production of IL-4, IL-5, IL-9 and IL-13, and this
immune response is commonly observed in tissues during allergic inflammation or infection …

Targeting metabolic dysregulation for fibrosis therapy

X Zhao, JYY Kwan, K Yip, PP Liu, FF Liu - Nature reviews Drug …, 2020 - nature.com
Fibrosis is the abnormal deposition of extracellular matrix, which can lead to organ
dysfunction, morbidity, and death. The disease burden caused by fibrosis is substantial, and …

The therapy of idiopathic pulmonary fibrosis: what is next?

V Somogyi, N Chaudhuri, SE Torrisi… - European …, 2019 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease, characterised by progressive scarring of the lung and associated with a high …

Targeting key proximal drivers of type 2 inflammation in disease

NA Gandhi, BL Bennett, NMH Graham… - Nature reviews Drug …, 2016 - nature.com
Systemic type 2 inflammation encompassing T helper 2 (TH2)-type responses is emerging
as a unifying feature of both classically defined allergic diseases, such as asthma, and a …

[HTML][HTML] Idiopathic pulmonary fibrosis (IPF): an overview

SL Barratt, A Creamer, C Hayton… - Journal of clinical …, 2018 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterised by chronic,
progressive scarring of the lungs and the pathological hallmark of usual interstitial …

[HTML][HTML] Airway remodeling in asthma: what really matters

H Fehrenbach, C Wagner, M Wegmann - Cell and tissue research, 2017 - Springer
Airway remodeling is generally quite broadly defined as any change in composition,
distribution, thickness, mass or volume and/or number of structural components observed in …

[HTML][HTML] Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages

L Chávez-Galán, ML Olleros, D Vesin… - Frontiers in …, 2015 - frontiersin.org
Monocytes are considered to be precursor cells of the mononuclear phagocytic system, and
macrophages are one of the leading members of this cellular system. Macrophages play …

[HTML][HTML] Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets

B Ballester, J Milara, J Cortijo - International journal of molecular sciences, 2019 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pulmonary
disease with a median survival of 2–4 years after diagnosis. A significant number of IPF …